These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Navigating the European biotechnology association labyrinth: A commentary on the role of biotechnology associations, selecting the most appropriate ones, and why now is the time to join. Suojanen C N Biotechnol; 2010 May; 27(2):95-9. PubMed ID: 20211280 [TBL] [Abstract][Full Text] [Related]
27. [Works council participation in the framework of company integration management]. Wenning-Morgenthaler M Rehabilitation (Stuttg); 2012 Jan; 51(1):55-7. PubMed ID: 22311398 [No Abstract] [Full Text] [Related]
28. The importance of matching talented leadership with the growth stage of your life-sciences company. Honeysett JM; Metheny R Nat Biotechnol; 2012 Jun; 30(6):563-5. PubMed ID: 22678402 [No Abstract] [Full Text] [Related]
30. The changing dynamics of strategic alliances between US biotechnology firms and Japanese corporations and universities. Bullock WO; Dibner MD Trends Biotechnol; 1994 Oct; 12(10):397-400. PubMed ID: 7765385 [No Abstract] [Full Text] [Related]
38. Partnerships between patients, medicine, and the biotechnology industry. Kent A; Tambuyzer E Nat Biotechnol; 1999 Oct; 17(10):935. PubMed ID: 10504676 [No Abstract] [Full Text] [Related]
39. Legal and social aspects of biotechnology in Poland. Twardowski T Acta Biochim Pol; 2005; 52(3):III-V. PubMed ID: 16475253 [No Abstract] [Full Text] [Related]